Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Geographic Atrophy Clinical Trials
Geographic Atrophy clinical trials are recruiting across 203 cities. Here are the cities with the most active studies:
Geographic Atrophy Trial Phases
83 research organizations are sponsoring geographic atrophy trials.
About Geographic Atrophy
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
Clinical trials are advancing new treatments for geographic atrophy. Currently, 100 studies are recruiting a combined 143,151 participants across the United States. Research is being conducted by 83 organizations including ClearNote Health, Genzyme, a Sanofi Company, Dana-Farber Cancer Institute and 80 others.
2026 Geographic Atrophy Research Landscape
As of July 2026, the geographic atrophy clinical trial landscape includes 100 actively recruiting studies across 203 cities in the United States. These studies are collectively seeking 143,151 participants, with an average enrollment target of 1,432 per study.
The research spans multiple phases of development: 26 studies are in NA, 26 studies are in PHASE3, 11 studies are in PHASE2, 4 studies are in PHASE1, 2 studies are in PHASE4. The presence of Phase 3 trials indicates that some geographic atrophy treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 83 different organizations, including ClearNote Health, Genzyme, a Sanofi Company, Dana-Farber Cancer Institute, California Pacific Medical Center Research Institute, Children's Hospital Medical Center, Cincinnati, and 78 others. The large number of sponsors reflects significant research interest and investment in geographic atrophy treatment advancement.
Geographically, geographic atrophy trials are most concentrated in Phoenix, Arizona (15 trials); Los Angeles, California (15 trials); Chicago, Illinois (14 trials); San Francisco, California (12 trials); Orange, California (10 trials) and 7 other cities.
Featured Geographic Atrophy Studies
Highlighted recruiting studies for geographic atrophy, selected by enrollment size and research scope.
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
ClearNote Health is developing a test from whole blood for the early detection of multiple cancers. The goal of this study is to employ genomics, epigenomics and proteomics methodology for the detection of cancer signal in the blood of subjects with solid tumors.
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives of the Re...
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Blood cancers occur when the molecules that control normal cell growth are damaged. Many of these changes can be detected by directly examining parts of the cancer or cells in blood. Several alterations that occur repeatedly in certain types of blood cancers have already been identified, and these discoveries have led to the development of new drugs that target those alterations. More remain to be...
Frequently Asked Questions About Geographic Atrophy Clinical Trials
Are there geographic atrophy clinical trials near me?
Yes, there are 100 geographic atrophy clinical trials currently recruiting across 203+ cities in the United States, including Phoenix, Arizona; Los Angeles, California; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a geographic atrophy clinical trial?
To join a geographic atrophy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are geographic atrophy clinical trials free?
Yes, participation in geographic atrophy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of geographic atrophy treatments are being studied?
Current geographic atrophy clinical trials are testing a range of approaches across NA (26 studies), PHASE3 (26 studies), PHASE2 (11 studies), PHASE1 (4 studies), PHASE4 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 83 research organizations.
Is it safe to participate in geographic atrophy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov